Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AcouSort ABOSTO:ACOU -6.67%43 3-Year EBITDA Growth Rate is 16.60% as of Mar. 2026. GuruFocus rates OSTO:ACOU with a GF Score™ of 43/100 and a GF Value™ of kr9.17 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,131 Biotechnology companies, AcouSort AB ranks better than 51.9% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 16.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 1.10% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -25.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of AcouSort AB was 16.60% per year. The lowest was -185.50% per year. And the median was -3.00% per year.
AcouSort AB (OSTO:ACOU) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
AcouSort AB 3-Year EBITDA Growth Rate Related Terms
OSTO:ACOU vs VRTX, REGN, RVMD: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, AcouSort AB's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AcouSort AB 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AcouSort AB's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where AcouSort AB's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 16.60% mean?
AcouSort AB (OSTO:ACOU) has a 3-Year EBITDA Growth Rate of 16.60% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for AcouSort AB and its competitors. According to the industry distribution chart, AcouSort AB ranks #544 out of 1131 companies in the Biotechnology industry, placing it in the top 48.1%.
Is AcouSort AB's 3-Year EBITDA Growth Rate too high?
AcouSort AB's current 3-Year EBITDA Growth Rate is 16.60%. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.90. AcouSort AB's value of 16.60% is 11.4% above this industry median. Based on the distribution chart, AcouSort AB ranks #544 out of 1131 companies in the Biotechnology industry, which is above the industry midpoint. Overall, AcouSort AB has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AcouSort AB's 3-Year EBITDA Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, AcouSort AB ranks #544 out of 1131 companies for 3-Year EBITDA Growth Rate. This puts AcouSort AB in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 14.90. AcouSort AB's value of 16.60% is 11.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.90, based on 1,131 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AcouSort AB's current 3-Year EBITDA Growth Rate of 16.60% is 11.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for AcouSort AB and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AcouSort AB's current 3-Year EBITDA Growth Rate is 16.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcouSort AB stock overvalued right now?
Based on GuruFocus' analysis, AcouSort AB (OSTO:ACOU) is currently considered Possible Value Trap. The stock's GF Value™ is kr9.17, compared to a current price of kr3.08 — trading 66.4% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 16.60% and 11.4% above the Biotechnology industry median of 14.90. AcouSort AB's overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For AcouSort AB (OSTO:ACOU), the current 3-Year EBITDA Growth Rate is 16.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AcouSort AB (OSTO:ACOU) Overvalued in 2026?
Based on GuruFocus' analysis, AcouSort AB stock appears to be undervalued.
The current stock price of kr3.08 is trading 66.4% below its estimated GF Value™ of kr9.17.
GuruFocus considers AcouSort AB to be Possible Value Trap.
Key valuation signals for OSTO:ACOU:
3-Year EBITDA Growth Rate: 16.60%
GF Value™: kr9.17 vs. price of kr3.08 (66.4% below fair value)
Industry Position: 11.4% above the Biotechnology median (#544 of 1131)
No single metric tells the full story. See the OSTO:ACOU stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AcouSort AB is a company that specializes in products and solutions for the automated preparation of biological samples for researchers and life science companies. Its technology is based on using ultrasound to isolate, separate, or trap microscopic particles such as blood cells, bacteria, or extracellular vesicles in microfluidic channels. The company's products includes AcouTrap, AcouWash, and AcouPlasma.
43GF Score
Get the complete analysis for OSTO:ACOU
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:ACOU has been successfully added to your 
